Skip to main content

Diabetes and Covid-19

New Content ItemSince the first reports of Covid-19 in Wuhan, China, research from all around the globe has confirmed the relationship between diabetes, hypertension and cardiovascular disease, and Covid-19 outcomes. The high frequencies of these comorbidities among hospitalized patients and in those with fatal outcome have shown their importance as risk factors for serious outcomes and lethality. 

In this Collection we publish research that investigates these relationships as well as treatment and prognosis, physiopathology, epidemiology and any other impact that Covid-19 may have on diabetic patients’ health.

Sergio Vencio and Marcello Bertoluci
Editor-in-Chief and Deputy Editor-in-Chief

Open for submissions. Check our submissions guidelines at the journal website.

Articles in the Collection

  1. The SARS-CoV-2 pandemic brought a radical shift in the healthcare system and suboptimal care for vulnerable patients, such as those with Type 2 Diabetes Mellitus (T2D). Therefore, we compared metabolic control...

    Authors: Devany Paola Morales-Rodriguez, Arnulfo González-Cantú, Arnulfo Garza-Silva, Andrea Rivera-Cavazos, Iván Francisco Fernández-Chau, Andrea Belinda Cepeda-Medina, Miguel Angel Sanz-Sánchez, Gerardo Francisco del Rio-Parra, María Angelina Torres-Fuentes, Miguel Assael Rodriguez-Puente and Maria Elena Romero-Ibarguengoitia
    Citation: Diabetology & Metabolic Syndrome 2024 16:94
  2. Data on hyperglycemia and glucose variability in relation to diabetes mellitus, either known or unknown in ICU-setting in COVID-19, are scarce. We prospectively studied daily glucose variables and mortality in...

    Authors: Thijs T.W. van Herpt, Frank van Rosmalen, Hendrica P.M.G. Hulsewé, Anouk N.A. van der Horst-Schrivers, Mariëlle Driessen, Robin Jetten, Noortje Zelis, Bastiaan E. de Galan, Sander M.J. van Kuijk, Iwan C.C. van der Horst and Bas C.T. van Bussel
    Citation: Diabetology & Metabolic Syndrome 2023 15:253
  3. The prognostic nutritional index (PNI) and different glucose metabolisms have been separately reported to be correlated with long-term prognosis in patients with acute myocardial infarction (AMI) undergoing pe...

    Authors: Xuebin Ling, Chufen Lin, Jin Liu, Yibo He, Yongquan Yang, Na Lu, Wei Jie, Yong Liu, Shiqun Chen and Junli Guo
    Citation: Diabetology & Metabolic Syndrome 2023 15:207
  4. The COVID-19 pandemic impacted diabetes care by reducing diabetes outpatient visits and diabetes-related screening due to allocation of healthcare resources. Yet the impact of COVID-19 on diabetes outpatients ...

    Authors: Jessica C.G. Bak, Erik H. Serné, Rolf H.H. Groenwold, Harold W. de Valk, Mark H.H. Kramer, Max Nieuwdorp and Carianne L. Verheugt
    Citation: Diabetology & Metabolic Syndrome 2023 15:193
  5. This study aimed to determine the association between glycemic variability (GV) and mortality in hospitalized patients with coronavirus disease 2019 (COVID-19).

    Authors: Salma Ali El Chab Parolin, Rebecca Benicio Stocco, Julia do Carmo Kneipp Lopes, Marcos Roberto Curcio Pereira, Milena Massae Yamashita, Maria Eduarda Domareski Goulart, Henrique Demeneck, Marcia Olandoski, Larissa Hermann de Souza Nunes, Victor Keniche Morisawa, Luiz Augusto Fanhani Cracco, Isabela Busto Silva, Jarbas Silva Motta Júnior, Daniela Veit Barreto, Gustavo Lenci Marques, Thyago Proença de Moraes…
    Citation: Diabetology & Metabolic Syndrome 2023 15:185
  6. The role of glycemic control, both prior and during hospitalization, on mortality from COVID-19 in diabetic patients is debated. Furthermore, it is not clear whether hyperglycemia has a direct effect or requir...

    Authors: Sara Madaschi, Eugenia Resmini, Silvia Bonfadini, Giulia Massari, Paola Gamba, Marco Sandri, Stefano Calza, Elena Cimino, Emanuela Zarra, Silvia Dotti, Cristina Mascadri, Barbara Agosti, Emirena Garrafa and Angela Girelli
    Citation: Diabetology & Metabolic Syndrome 2022 14:168
  7. During pandemic period, a single fast glycemia value (≥ 92 mg/dl) performed within the recommended time window for the risk level defined by the Italian guidelines, was considered an acceptable surrogate for G...

    Authors: Rosario D’Anna, Antonio Di Benedetto, Stefania Palella, Alessia Miceli, Paola Romeo and Francesco Corrado
    Citation: Diabetology & Metabolic Syndrome 2022 14:164
  8. The clustering of metabolic abnormalities may weaken vaccine-induced immunity, but epidemiological data regarding SARS-CoV-2 vaccines are scarce. The present study aimed to examine the cross-sectional associat...

    Authors: Dong Van Hoang, Shohei Yamamoto, Ami Fukunaga, Yosuke Inoue, Tetsuya Mizoue and Norio Ohmagari
    Citation: Diabetology & Metabolic Syndrome 2022 14:149
  9. Starting December 2019, the world has been devastated by the rapid spread of coronavirus disease 2019 (Covid-19). Many risk factors have been associated with worse outcomes and death from Covid-19 pneumonia in...

    Authors: Marc Assaad, Nakisa Hekmat-Joo, Jeff Hosry, Ali Kassem, Ahmad Itani, Loai Dahabra, Ahmad Abou Yassine, Julie Zaidan and Dany El Sayegh
    Citation: Diabetology & Metabolic Syndrome 2022 14:85

    The Correction to this article has been published in Diabetology & Metabolic Syndrome 2022 14:98

  10. Optimal glycemic control is the main goal for patients with diabetes. The results of type 1 diabetes patients’ neglected demands during the pandemic can determine a long-term negative clinical, social, and eco...

    Authors: Luciana Foppa, Janine Alessi, Betina Nemetz, Rosimeri de Matos, Gabriela Heiden Telo and Beatriz D. Schaan
    Citation: Diabetology & Metabolic Syndrome 2022 14:75
  11. The COVID-19 pandemic led to an unprecedented crisis, and early on, it has been shown that diabetes is an important risk factor for complications and mortality in infected patients, as demonstrated by several ...

    Authors: Thiago Bosco Mendes, Alexandre Barbosa Câmara-de-Souza and Bruno Halpern
    Citation: Diabetology & Metabolic Syndrome 2022 14:37
  12. People with diabetes are at a greater risk of serious complications from Coronavirus disease (COVID-19). Self-management of diabetes is therefore of paramount importance. The purpose of this study is to compar...

    Authors: Shahina Pardhan, Md. Saiful Islam, Guillermo F. López-Sánchez, Tirthalal Upadhyaya and Raju P. Sapkota
    Citation: Diabetology & Metabolic Syndrome 2021 13:123
  13. One possible reason for increased mortality due to SARS-CoV-2 in patients with diabetes is from the complication of diabetic ketoacidosis (DKA).

    Authors: Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, Ali A. Rabaan, Mohammed A. Alomari, Sadiq A. Al Salman, Ahmed S. Al-Alawi, Mohammed H. Al Hassan, Hesham Alhamad, Mustafa A. Al-kamees, Fawzi M. Almousa, Hani N. Mufti, Ali M. Alwesabai, Kuldeep Dhama, Jaffar A. Al-Tawfiq and Awad Al-Omari
    Citation: Diabetology & Metabolic Syndrome 2021 13:120
  14. In 2019, a new virus known as severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has emerged. Coronavirus disease 2019 (COVID-19) was classified as a pandemic in a short period of time. In order...

    Authors: Claudia Eberle and Stefanie Stichling
    Citation: Diabetology & Metabolic Syndrome 2021 13:95
  15. The world guidance on the measures of social distancing for prevention of COVID-19 has changed the daily habits of great part of the population, and this could influence the care and resilience with diabetes d...

    Authors: Bárbara Aparecida Binhardi, Carla Regina de Souza Teixeira, Bianca de Almeida-Pititto, Francisco Barbosa-Junior, Laercio Joel Franco, Karla Fabiana Santana de Melo, Domingos Augusto Cherino Malerbi and Rinaldo Eduardo Machado de Oliveira
    Citation: Diabetology & Metabolic Syndrome 2021 13:87
  16. COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population represents only 2.6% of the world population...

    Authors: Rodrigo Esaki Tamura, Said Muhammad Said, Leticia Mussin de Freitas and Ileana Gabriela Sanchez Rubio
    Citation: Diabetology & Metabolic Syndrome 2021 13:76
  17. A new strain of human coronavirus (HCoV) spread rapidly around the world. Diabetes and obesity are associated with a worse prognosis in these patients. Congenital Generalized Lipodystrophy (CGL) patients gener...

    Authors: Mayara Ponte Madeira, Erika Bastos Lima Freire, Virginia Oliveira Fernandes, Grayce Ellen da Cruz Paiva Lima, Ivana da Ponte Melo, Ana Paula Dias Rangel Montenegro, José Ednésio da Cruz Freire, Caroline de Fátima Aquino Moreira-Nunes, Raquel Carvalho Montenegro, Jeová Keny Baima Colares and Renan Magalhães Montenegro Junior
    Citation: Diabetology & Metabolic Syndrome 2021 13:65
  18. The COVID-19 pandemic is a global public health emergency, which presents wide-ranging negative impacts on individuals with diabetes. To examine psychosocial well-being and diabetes outcomes in individuals wit...

    Authors: Samereh Abdoli, Monica S. V. M. Silveira, Mehri Doosti-Irani, Paulo Fanti, Katherine Miller-Bains, Elizabeth João Pavin, Edimariz Buin Cardoso, Leila Rafiee Vardanjani, Kobra Noorian and Danielle Hessler
    Citation: Diabetology & Metabolic Syndrome 2021 13:63

    The Correction to this article has been published in Diabetology & Metabolic Syndrome 2021 13:78

  19. Our understanding of the pathophysiology of the COVID-19 manifestations and evolution has improved over the past 10 months, but the reasons why evolution is more severe in obese and diabetic patients are not y...

    Authors: Andrey Santos, Daniéla Oliveira Magro, Rosana Evangelista-Poderoso and Mario José Abdalla Saad
    Citation: Diabetology & Metabolic Syndrome 2021 13:23
  20. A dysregulated host immune response is common in patients with COVID-19.

    Authors: Dafeng Liu, Yong Wang, Bennan Zhao, Lijuan Lan, Yaling Liu, Lei Bao, Hong Chen, Min Yang, Qingfeng Li and Yilan Zeng
    Citation: Diabetology & Metabolic Syndrome 2021 13:5
  21. The disclosure in the media of a benefit with the use of dexamethasone in patients with COVID-19 infection sets precedents for self-medication and inappropriate use of corticosteroids.

    Authors: Janine Alessi, Giovana B. de Oliveira, Beatriz D. Schaan and Gabriela H. Telo
    Citation: Diabetology & Metabolic Syndrome 2020 12:80
  22. In patients with diabetes, the prevalence of depression and anxiety symptoms is about two to four times greater than in the general population. The association between diabetes and mental health disorders coul...

    Authors: Janine Alessi, Giovana Berger de Oliveira, Debora Wilke Franco, Bibiana Brino do Amaral, Alice Scalzilli Becker, Carolina Padilla Knijnik, Gabriel Luiz Kobe, Taíse Rosa de Carvalho, Guilherme Heiden Telo, Beatriz D. Schaan and Gabriela Heiden Telo
    Citation: Diabetology & Metabolic Syndrome 2020 12:76
  23. The aim of this study is to evaluate the impact of diabetes, hypertension, cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin II receptor blockers (ACEI/ARB) with severi...

    Authors: Bianca de Almeida-Pititto, Patrícia M. Dualib, Lenita Zajdenverg, Joana Rodrigues Dantas, Filipe Dias de Souza, Melanie Rodacki and Marcello Casaccia Bertoluci
    Citation: Diabetology & Metabolic Syndrome 2020 12:75
  24. Chronic inflammation is involved in the pathogenesis of several metabolic diseases, such as obesity and type 2 diabetes mellitus (T2DM). With the recent worldwide outbreak of coronavirus disease (SARS-CoV-2), ...

    Authors: Mauricio Krause, Fernando Gerchman and Rogério Friedman
    Citation: Diabetology & Metabolic Syndrome 2020 12:63
  25. Diabetes mellitus (DM) and cardiovascular disease (CVD) are present in a large number of patients with novel Coronavirus disease 2019 (COVID-19). We aimed to determine the risk and predictors of in-hospital mo...

    Authors: Hadith Rastad, Hossein Karim, Hanieh-Sadat Ejtahed, Ramin Tajbakhsh, Mohammad Noorisepehr, Mehrdad Babaei, Mehdi Azimzadeh, Alireza Soleimani, Seyed Hasan Inanloo, Neda Shafiabadi Hassani, Fariba Rasanezhad, Ehsan Shahrestanaki, Zeinab Khodaparast, Hossein Golami and Mostafa Qorbani
    Citation: Diabetology & Metabolic Syndrome 2020 12:57